论文部分内容阅读
目的:探究阿奇霉素治疗成人呼吸道感染的临床疗效。方法:选取收治区间为2016年12月至2017年2月的64例成人呼吸道感染患者作为本次临床研究对象,并将其随机平均分成两组,每小组有32例患者,对对照组患者采用静脉注射红霉素的方式进行治疗,对观察组患者采用静脉注射阿奇霉素的方式进行治疗。结果:使用阿奇霉素治疗的观察组患者治疗总有效率明显高于对照组患者,且观察组患者疾病好转时间普遍短于对照组患者疾病好转时间。结论:阿奇霉素在治疗成人呼吸道感染方面具有显著的效果,能够作为治疗呼吸道感染疾病的首选药物,有利于患者生活质量的提高,因此建议在临床应用中进行广泛推广。
Objective: To investigate the clinical efficacy of azithromycin in the treatment of adult respiratory infections. Methods: Sixty-four adult patients with respiratory tract infection from December 2016 to February 2017 were selected and divided into two groups randomly, with 32 patients in each group. Patients in the control group were enrolled in this study Intravenous injection of erythromycin for treatment, the observation group patients treated with intravenous azithromycin treatment. Results: The total effective rate of patients in the observation group treated with azithromycin was significantly higher than that in the control group, and the improvement time of disease in the observation group was generally shorter than that of the control group. Conclusion: Azithromycin has a significant effect in the treatment of adult respiratory infections and can be used as the drug of choice for the treatment of respiratory tract infections, which is beneficial to the improvement of patients’ quality of life. Therefore, it is recommended to be widely used in clinical practice.